Mark A. Glickman, EVP - Sales and Marketing at AUXILIUM PHARMACEUTICALS INC (AUXL), sold 47,952 shares at $33.18 ($1.6M) on 2014-11-20, disclosed to the SEC on 2014-11-24.
Open-market sale of $1.6M AUXL by EVP - Sales and Marketing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.16 | 40,750 | $1.4M | 85.0% |
| 2 | $33.18 | 7,202 | $239K | 15.0% |
| Total | $33.16 avg | 47,952 | $1.6M | 100% |
| Filing → |
| ARLZ | BUY | 2016-05-18 | $92K | — | Filing → |